Prolonged treatment with the atypical antipsychotic agent remoxipride reduces extracellular glutamate levels in the striatum of freely moving rats.
Magnusson
O
O
Department of Pharmacology, Astra Arcus AB, Södertälje, Sweden.
Serrano-Lundkvist
G
G
Henriksson
I
I
Mohringe
B
B
Ogren
S O
SO
D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D003956:Dialysis; D018698:Glutamic Acid / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D017330:Remoxipride / Q000008:administration & dosage / Q000494:pharmacology*
D014150:Antipsychotic Agents; D017330:Remoxipride; D018698:Glutamic Acid